Show simple item record

A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease - The International Verapamil-Trandolapril Study (INVEST): A randomized controlled trial

dc.contributor.authorMancia, G
dc.contributor.authorMesserli, FH
dc.contributor.authorKeltai, M
dc.contributor.authorGarcia-Barreto, D
dc.contributor.authorCangiano, JL
dc.contributor.authorParmley, WW
dc.contributor.authorPepine, CJ
dc.contributor.authorHandberg, EM
dc.contributor.authorCooper-Dehoff, RM
dc.contributor.authorMarks, RG
dc.contributor.authorKowey, P
dc.contributor.authorCohen, JD
dc.contributor.authorBakris, GL
dc.contributor.authorKolb, HR
dc.contributor.authorBristol, HA
dc.contributor.authorErdine, S
dc.date.accessioned2021-03-04T08:12:25Z
dc.date.available2021-03-04T08:12:25Z
dc.date.issued2003
dc.identifier.citationPepine C., Handberg E., Cooper-Dehoff R., Marks R., Kowey P., Messerli F., Mancia G., Cangiano J., Garcia-Barreto D., Keltai M., et al., "A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease - The International Verapamil-Trandolapril Study (INVEST): A randomized controlled trial", JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, cilt.290, sa.21, ss.2805-2816, 2003
dc.identifier.issn0098-7484
dc.identifier.othervv_1032021
dc.identifier.otherav_6227170c-e712-4101-a6b5-4bce201970e4
dc.identifier.urihttp://hdl.handle.net/20.500.12627/68367
dc.identifier.urihttps://doi.org/10.1001/jama.290.21.2805
dc.description.abstractContext Despite evidence of efficacy of anti hypertensive agents in treating hypertensive patients, safety and efficacy of anti hypertensive agents for coronary artery disease (CAD) have been discerned only from subgroup analyses in large trials.
dc.language.isoeng
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTemel Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectTIP, GENEL & İÇECEK
dc.titleA calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease - The International Verapamil-Trandolapril Study (INVEST): A randomized controlled trial
dc.typeMakale
dc.relation.journalJAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
dc.contributor.department, ,
dc.identifier.volume290
dc.identifier.issue21
dc.identifier.startpage2805
dc.identifier.endpage2816
dc.contributor.firstauthorID170118


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record